These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32624038)

  • 21. Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Pisapia R; Gärtner B; Berger FK; Reigadas E; Bouza E; Demont C; Wilcox MH
    Anaerobe; 2020 Apr; 62():102178. PubMed ID: 32092415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-year epidemiological analysis of Clostridioides difficile infection and the value of hospital-infection control measures in a tertiary-care teaching hospital in Japan using PCR-based open-reading frame typing.
    Nakaie K; Yamada K; Kuwabara G; Imoto W; Yamairi K; Shibata W; Oshima K; Niki M; Sakurai N; Nonose Y; Okada Y; Fujita A; Kaneko Y; Kakeya H
    J Infect Chemother; 2021 Feb; 27(2):179-184. PubMed ID: 32950394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridioides difficile infections in Alberta: The validity of administrative data using ICD-10 diagnostic codes for CDI surveillance versus clinical infection surveillance.
    Pfister T; Rennert-May E; Ellison J; Bush K; Leal J
    Am J Infect Control; 2020 Dec; 48(12):1431-1436. PubMed ID: 32810568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent Clostridioides difficile Infections: Should We Respond More to Toxin B?
    Schriever CA; Danziger LH
    Clin Infect Dis; 2020 Jun; 71(1):87-88. PubMed ID: 31584630
    [No Abstract]   [Full Text] [Related]  

  • 25. The future of Clostridioides difficile diagnostics.
    Mizusawa M; Carroll KC
    Curr Opin Infect Dis; 2021 Oct; 34(5):483-490. PubMed ID: 34524199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Search of the (Clostridium difficile) Holy Grail.
    Pardi DS; Khanna S
    Clin Infect Dis; 2020 Mar; 70(6):1094-1095. PubMed ID: 31125415
    [No Abstract]   [Full Text] [Related]  

  • 27. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridioides (Clostridium) difficile in neonatal foals and mares at a referral hospital.
    Weese JS; Slovis N; Rousseau J
    J Vet Intern Med; 2021 Mar; 35(2):1140-1146. PubMed ID: 33656757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridioides difficile Infection in Children: Research Progress, Pitfalls, and Priorities.
    Kociolek LK; Burnham CD; Nicholson MR; Zackular JP
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S1-S2. PubMed ID: 34791394
    [No Abstract]   [Full Text] [Related]  

  • 30. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
    Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Clostridioides difficile in hospital environment by using C diff Banana Broth™.
    Kabała M; Gofron Z; Aptekorz M; Burdynowski K; Harmanus C; Kuijper E; Martirosian G
    Anaerobe; 2022 Feb; 73():102408. PubMed ID: 34174400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
    Karlowsky JA; Adam HJ; Baxter MR; Dutka CW; Nichol KA; Laing NM; Golding GR; Zhanel GG
    J Antimicrob Chemother; 2020 Jul; 75(7):1824-1832. PubMed ID: 32294172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilizing a real-time discussion approach to improve the appropriateness of
    Dbeibo L; Brinkman A; Beeler C; Fadel W; Snyderman W; Hatfield N; Sadowski J; Wang Y; Kelley K; Webb D; Azar J; Kara A
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1215-1218. PubMed ID: 32594961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interpretation of group standard for
    Wu Y; Lu JX; Yan ZZ; Liu YX; Gu WP; Fu XQ; Xu YC; Wu AH; Huang HH; Zong ZY; Jin DZ; Zhao JH; Chen Y; Liu WP; Li WG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):64-67. PubMed ID: 33503698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What do we know about the diagnostics, treatment and epidemiology of Clostridioides (Clostridium) difficile infection in Europe?
    Nagy E
    J Infect Chemother; 2018 Mar; 24(3):164-170. PubMed ID: 29289484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Multicenter Study of the Revogene C. difficile System for Detection of the Toxin B Gene from Unformed Stool Specimens.
    Mashock MJ; Faron ML; Carroll KC; Dang C; Lewis S; Salimnia H; Lephart P; Loo VG; Schmitt BH; Young S; Buchan BW; Ledeboer NA
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776191
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results.
    Shah MD; Balada-Llasat JM; Coe K; Reed E; Sandlund J; Pancholi P
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32051264
    [No Abstract]   [Full Text] [Related]  

  • 40. Achieving and maintaining low rates of hospital-onset
    LaPorte MRC; Bruno-Murtha LA
    Infect Control Hosp Epidemiol; 2020 Aug; 41(8):995-997. PubMed ID: 32408913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.